Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.

Tian S, Zhang X, Jiang R, Pillai RN, Owonikoko TK, Steuer CE, Saba NF, Pakkala S, Patel PR, Belani CP, Khuri FR, Curran WJ, Ramalingam SS, Behera M, Higgins KA.

Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30156-1. doi: 10.1016/j.cllc.2019.06.014. [Epub ahead of print]

PMID:
31296433
2.

New Treatment Options in Advanced Squamous Cell Lung Cancer.

Paik PK, Pillai RN, Lathan CS, Velasco SA, Papadimitrakopoulou V.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:e198-e206. doi: 10.1200/EDBK_237829. Epub 2019 May 17.

PMID:
31099625
3.

Advanced-Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018.

Remon J, Ahn MJ, Girard N, Johnson M, Kim DW, Lopes G, Pillai RN, Solomon B, Villacampa G, Zhou Q.

J Thorac Oncol. 2019 Jul;14(7):1134-1155. doi: 10.1016/j.jtho.2019.03.022. Epub 2019 Apr 16. Review.

PMID:
31002952
4.

Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience.

El Osta B, Behera M, Kim S, Berry LD, Sica G, Pillai RN, Owonikoko TK, Kris MG, Johnson BE, Kwiatkowski DJ, Sholl LM, Aisner DL, Bunn PA, Khuri FR, Ramalingam SS.

J Thorac Oncol. 2019 May;14(5):876-889. doi: 10.1016/j.jtho.2019.01.020. Epub 2019 Feb 5.

PMID:
30735816
5.

Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.

Martini DJ, Liu Y, Shabto JM, Lewis C, Kline MR, Collins H, Akce M, Kissick HT, Carthon BC, Shaib WL, Alese OB, Pillai RN, Steuer CE, Wu CS, Lawson DH, Kudchadkar RR, Master VA, El-Rayes BF, Ramalingam SS, Owonikoko TK, Harvey RD, Bilen MA.

Invest New Drugs. 2019 Feb 6. doi: 10.1007/s10637-019-00736-0. [Epub ahead of print]

PMID:
30725388
6.

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.

Bilen MA, Martini DJ, Liu Y, Lewis C, Collins HH, Shabto JM, Akce M, Kissick HT, Carthon BC, Shaib WL, Alese OB, Pillai RN, Steuer CE, Wu CS, Lawson DH, Kudchadkar RR, El-Rayes BF, Master VA, Ramalingam SS, Owonikoko TK, Harvey RD.

Cancer. 2019 Jan 1;125(1):127-134. doi: 10.1002/cncr.31778. Epub 2018 Oct 17.

PMID:
30329148
7.

Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.

Press RH, Zhang C, Cassidy RJ, Ferris MJ, Zhong J, Steuer CE, Pillai RN, Owonikoko TK, Kahn S, Ramalingam SS, Patel PR, Curran WJ, Shu HG, Sica GL, Higgins KA.

Cancer. 2018 Sep 1;124(17):3586-3595. doi: 10.1002/cncr.31589. Epub 2018 Aug 18.

8.

Throwing More Cold Water on Heat Shock Protein 90 Inhibitors in NSCLC.

Pillai RN, Ramalingam SS.

J Thorac Oncol. 2018 Apr;13(4):473-474. doi: 10.1016/j.jtho.2018.02.010. No abstract available.

9.

CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.

Hashimoto M, Kamphorst AO, Im SJ, Kissick HT, Pillai RN, Ramalingam SS, Araki K, Ahmed R.

Annu Rev Med. 2018 Jan 29;69:301-318. doi: 10.1146/annurev-med-012017-043208. Review.

PMID:
29414259
10.

Health care disparities among octogenarians and nonagenarians with stage III lung cancer.

Cassidy RJ, Zhang X, Switchenko JM, Patel PR, Shelton JW, Tian S, Nanda RH, Steuer CE, Pillai RN, Owonikoko TK, Ramalingam SS, Fernandez FG, Force SD, Gillespie TW, Curran WJ, Higgins KA.

Cancer. 2018 Feb 15;124(4):775-784. doi: 10.1002/cncr.31077. Epub 2018 Jan 8.

11.

Prediction of miscarriage in women with viable intrauterine pregnancy-A systematic review and diagnostic accuracy meta-analysis.

Pillai RN, Konje JC, Richardson M, Tincello DG, Potdar N.

Eur J Obstet Gynecol Reprod Biol. 2018 Jan;220:122-131. doi: 10.1016/j.ejogrb.2017.10.024. Epub 2017 Nov 4. Review.

PMID:
29207325
12.

Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature.

Pillai RN, Behera M, Owonikoko TK, Kamphorst AO, Pakkala S, Belani CP, Khuri FR, Ahmed R, Ramalingam SS.

Cancer. 2018 Jan 15;124(2):271-277. doi: 10.1002/cncr.31043. Epub 2017 Sep 28.

13.

Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.

Higgins KA, Pillai RN, Chen Z, Tian S, Zhang C, Patel P, Pakkala S, Shelton J, Force SD, Fernandez FG, Steuer CE, Owonikoko TK, Ramalingam SS, Bradley JD, Curran WJ.

J Thorac Oncol. 2017 Nov;12(11):1687-1695. doi: 10.1016/j.jtho.2017.07.036. Epub 2017 Sep 13.

14.

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.

Pillai RN, Behera M, Berry LD, Rossi MR, Kris MG, Johnson BE, Bunn PA, Ramalingam SS, Khuri FR.

Cancer. 2017 Nov 1;123(21):4099-4105. doi: 10.1002/cncr.30869. Epub 2017 Jul 25.

15.

Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.

Cassidy RJ, Zhang X, Patel PR, Shelton JW, Escott CE, Sica GL, Rossi MR, Hill CE, Steuer CE, Pillai RN, Ramalingam SS, Owonikoko TK, Behera M, Force SD, Fernandez FG, Curran WJ, Higgins KA.

Cancer. 2017 Oct 1;123(19):3681-3690. doi: 10.1002/cncr.30794. Epub 2017 Jun 13.

16.

Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.

Ahmed HZ, Liu Y, O'Connell K, Ahmed MZ, Cassidy RJ, Gillespie TW, Patel P, Pillai RN, Behera M, Steuer CE, Owonikoko TK, Ramalingam SS, Curran WJ, Higgins KA.

Clin Lung Cancer. 2017 Nov;18(6):706-718. doi: 10.1016/j.cllc.2017.04.009. Epub 2017 Apr 28.

PMID:
28601387
17.

Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.

Kamphorst AO, Pillai RN, Yang S, Nasti TH, Akondy RS, Wieland A, Sica GL, Yu K, Koenig L, Patel NT, Behera M, Wu H, McCausland M, Chen Z, Zhang C, Khuri FR, Owonikoko TK, Ahmed R, Ramalingam SS.

Proc Natl Acad Sci U S A. 2017 May 9;114(19):4993-4998. doi: 10.1073/pnas.1705327114. Epub 2017 Apr 26.

18.

Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.

Cassidy RJ, Patel PR, Zhang X, Press RH, Switchenko JM, Pillai RN, Owonikoko TK, Ramalingam SS, Fernandez FG, Force SD, Curran WJ, Higgins KA.

Clin Lung Cancer. 2017 Sep;18(5):551-558.e6. doi: 10.1016/j.cllc.2017.03.006. Epub 2017 Mar 16.

19.

Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy.

Rydén A, Blackhall F, Kim HR, Pillai RN, Braam L, Martin ML, Walding A.

Patient. 2017 Oct;10(5):593-603. doi: 10.1007/s40271-017-0229-9.

PMID:
28353220
20.

Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.

Kamphorst AO, Wieland A, Nasti T, Yang S, Zhang R, Barber DL, Konieczny BT, Daugherty CZ, Koenig L, Yu K, Sica GL, Sharpe AH, Freeman GJ, Blazar BR, Turka LA, Owonikoko TK, Pillai RN, Ramalingam SS, Araki K, Ahmed R.

Science. 2017 Mar 31;355(6332):1423-1427. doi: 10.1126/science.aaf0683. Epub 2017 Mar 9.

21.

Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.

Steuer CE, Behera M, Liu Y, Fu C, Gillespie TW, Saba NF, Shin DM, Pillai RN, Pakkala S, Owonikoko TK, Khuri FR, Ramalingam SS.

Clin Lung Cancer. 2017 May;18(3):286-292. doi: 10.1016/j.cllc.2016.11.016. Epub 2016 Dec 7.

PMID:
28043773
22.

National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer.

Higgins KA, O'Connell K, Liu Y, Gillespie TW, McDonald MW, Pillai RN, Patel KR, Patel PR, Robinson CG, Simone CB 2nd, Owonikoko TK, Belani CP, Khuri FR, Curran WJ, Ramalingam SS, Behera M.

Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):128-137. doi: 10.1016/j.ijrobp.2016.10.001. Epub 2016 Oct 11.

23.

Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review.

Steuer CE, Behera M, Ernani V, Higgins KA, Saba NF, Shin DM, Pakkala S, Pillai RN, Owonikoko TK, Curran WJ, Belani CP, Khuri FR, Ramalingam SS.

JAMA Oncol. 2017 Aug 1;3(8):1120-1129. doi: 10.1001/jamaoncol.2016.4280. Review.

PMID:
27978552
24.

Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report.

Owonikoko TK, Kumar M, Yang S, Kamphorst AO, Pillai RN, Akondy R, Nautiyal V, Chatwal MS, Book WM, Sahu A, Sica GL, Ahmed R, Ramalingam SS.

Cancer Immunol Immunother. 2017 Jan;66(1):45-50. doi: 10.1007/s00262-016-1918-2. Epub 2016 Oct 22.

25.

Mean population salt consumption in India: a systematic review.

Johnson C, Praveen D, Pope A, Raj TS, Pillai RN, Land MA, Neal B.

J Hypertens. 2017 Jan;35(1):3-9. Review.

26.

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.

Sharma P, Callahan MK, Bono P, Kim J, Spiliopoulou P, Calvo E, Pillai RN, Ott PA, de Braud F, Morse M, Le DT, Jaeger D, Chan E, Harbison C, Lin CS, Tschaika M, Azrilevich A, Rosenberg JE.

Lancet Oncol. 2016 Nov;17(11):1590-1598. doi: 10.1016/S1470-2045(16)30496-X. Epub 2016 Oct 9. Erratum in: Lancet Oncol. 2019 Feb;20(2):e71.

27.

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.

Antonia SJ, López-Martin JA, Bendell J, Ott PA, Taylor M, Eder JP, Jäger D, Pietanza MC, Le DT, de Braud F, Morse MA, Ascierto PA, Horn L, Amin A, Pillai RN, Evans J, Chau I, Bono P, Atmaca A, Sharma P, Harbison CT, Lin CS, Christensen O, Calvo E.

Lancet Oncol. 2016 Jul;17(7):883-895. doi: 10.1016/S1470-2045(16)30098-5. Epub 2016 Jun 4. Erratum in: Lancet Oncol. 2016 Jul;17 (7):e270. Erratum in: Lancet Oncol. 2019 Feb;20(2):e70.

PMID:
27269741
28.

Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.

Behera M, Owonikoko TK, Gal AA, Steuer CE, Kim S, Pillai RN, Khuri FR, Ramalingam SS, Sica GL.

Clin Lung Cancer. 2016 Sep;17(5):e57-e64. doi: 10.1016/j.cllc.2016.03.009. Epub 2016 Mar 30. Review.

PMID:
27137345
29.

Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.

Fisher KE, Zhang L, Wang J, Smith GH, Newman S, Schneider TM, Pillai RN, Kudchadkar RR, Owonikoko TK, Ramalingam SS, Lawson DH, Delman KA, El-Rayes BF, Wilson MM, Sullivan HC, Morrison AS, Balci S, Adsay NV, Gal AA, Sica GL, Saxe DF, Mann KP, Hill CE, Khuri FR, Rossi MR.

J Mol Diagn. 2016 Mar;18(2):299-315. doi: 10.1016/j.jmoldx.2015.11.006. Epub 2016 Jan 20.

30.

Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis.

Pillai RN, Konje JC, Tincello DG, Potdar N.

Hum Reprod Update. 2016 Mar-Apr;22(2):228-39. doi: 10.1093/humupd/dmv054. Epub 2015 Dec 9. Review.

PMID:
26663220
31.

Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005.

Behera M, Ragin C, Kim S, Pillai RN, Chen Z, Steuer CE, Saba NF, Belani CP, Khuri FR, Ramalingam SS, Owonikoko TK.

Cancer. 2016 Jan 1;122(1):50-60. doi: 10.1002/cncr.29674. Epub 2015 Oct 6.

32.

Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic Review.

Behera M, Pillai RN, Owonikoko TK, Kim S, Steuer C, Chen Z, Saba NF, Belani CP, Khuri FR, Ramalingam SS.

J Thorac Oncol. 2015 Aug;10(8):1142-7. doi: 10.1097/JTO.0000000000000572. Review.

33.

Necitumumab: a new therapeutic option for squamous cell lung cancer?

Pillai RN, Ramalingam SS.

Transl Lung Cancer Res. 2014 Dec;3(6):382-3. doi: 10.3978/j.issn.2218-6751.2014.11.01. No abstract available.

34.

Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.

Mikell JL, Gillespie TW, Hall WA, Nickleach DC, Liu Y, Lipscomb J, Ramalingam SS, Rajpara RS, Force SD, Fernandez FG, Owonikoko TK, Pillai RN, Khuri FR, Curran WJ, Higgins KA.

J Thorac Oncol. 2015 Mar;10(3):462-71. doi: 10.1097/JTO.0000000000000411.

35.

Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis.

Steuer CE, Behera M, Kim S, Chen Z, Saba NF, Pillai RN, Owonikoko TK, Khuri FR, Ramalingam SS.

J Thorac Oncol. 2015 Mar;10(3):479-85. doi: 10.1097/JTO.0000000000000419.

36.

Section IV: non-small cell lung cancer and malignant melanoma.

Fisher KE, Pillai RN, Kudchadkar RR, Rossi MR.

Curr Probl Cancer. 2014 Sep-Oct;38(5):180-98. doi: 10.1016/j.currproblcancer.2014.08.007. Epub 2014 Aug 14. Review. No abstract available.

PMID:
25281457
37.

Introduction: molecular genomics of cancer: linking diagnostic testing and clinical therapy.

Fisher KE, Neill SG, Smith GH, Pillai RN, Kudchadkar RR, Zhang L, Rossi MR.

Curr Probl Cancer. 2014 Sep-Oct;38(5):142-3. doi: 10.1016/j.currproblcancer.2014.08.003. Epub 2014 Aug 14. No abstract available.

PMID:
25220586
38.

Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501).

Pillai RN, Aisner J, Dahlberg SE, Rogers JS, DiPaola RS, Aisner S, Ramalingam SS, Schiller JH.

Cancer Chemother Pharmacol. 2014 Jul;74(1):177-83. doi: 10.1007/s00280-014-2427-7. Epub 2014 May 24.

39.

Small cell lung cancer: therapies and targets.

Pillai RN, Owonikoko TK.

Semin Oncol. 2014 Feb;41(1):133-42. doi: 10.1053/j.seminoncol.2013.12.015. Epub 2013 Dec 12. Review.

40.

Advances in the diagnosis and treatment of non-small cell lung cancer.

Pillai RN, Ramalingam SS.

Mol Cancer Ther. 2014 Mar;13(3):557-64. doi: 10.1158/1535-7163.MCT-13-0669. Epub 2014 Feb 10.

41.

Heat shock protein 90 inhibitors in non-small-cell lung cancer.

Pillai RN, Ramalingam SS.

Curr Opin Oncol. 2014 Mar;26(2):159-64. doi: 10.1097/CCO.0000000000000047. Review.

PMID:
24463348
42.

CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.

Pillai RN, Brodie SA, Sica GL, Shaojin Y, Li G, Nickleach DC, Yuan L, Varma VA, Bonta D, Herman JG, Brock MV, Ribeiro MJ, Ramalingam SS, Owonikoko TK, Khuri FR, Brandes JC.

Clin Cancer Res. 2013 Mar 15;19(6):1603-11. doi: 10.1158/1078-0432.CCR-12-2995. Epub 2013 Feb 5.

43.

Inhibition of insulin-like growth factor receptor: end of a targeted therapy?

Pillai RN, Ramalingam SS.

Transl Lung Cancer Res. 2013 Feb;2(1):14-22. doi: 10.3978/j.issn.2218-6751.2012.11.05. Review.

44.

Hsp90 inhibitors.

Pillai RN, Ramalingam SS.

J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S407-8. doi: 10.1097/JTO.0b013e31826df2bb. Review. No abstract available.

45.

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

Pillai RN, Chen LS, Ayres ML, Nowak BJ, Thomas MW, Shpall EJ, Keating MJ, Gandhi V.

Leuk Lymphoma. 2012 Oct;53(10):2024-32. doi: 10.3109/10428194.2012.678003. Epub 2012 Apr 23.

46.

The biology and clinical features of non-small cell lung cancers with EML4-ALK translocation.

Pillai RN, Ramalingam SS.

Curr Oncol Rep. 2012 Apr;14(2):105-10. doi: 10.1007/s11912-012-0213-4. Review.

PMID:
22311682
47.

An association of purple urine bag syndrome with intussusception.

Pillai RN, Clavijo J, Narayanan M, Zaman K.

Urology. 2007 Oct;70(4):812.e1-2.

PMID:
17991574
48.

Occupancy of a single anesthetic binding pocket is sufficient to enhance glycine receptor function.

Roberts MT, Phelan R, Erlichman BS, Pillai RN, Ma L, Lopreato GF, Mihic SJ.

J Biol Chem. 2006 Feb 10;281(6):3305-11. Epub 2005 Dec 16.

49.

Early overuse and disuse of the affected forelimb after moderately severe intraluminal suture occlusion of the middle cerebral artery in rats.

Bland ST, Pillai RN, Aronowski J, Grotta JC, Schallert T.

Behav Brain Res. 2001 Nov 29;126(1-2):33-41.

PMID:
11704249
50.

Salt tolerance of Rhizobium from Dolichos lablab.

Pillai RN, Sen A.

Zentralbl Bakteriol Parasitenkd Infektionskr Hyg. 1973;128(5):538-42. No abstract available.

PMID:
4801560

Supplemental Content

Loading ...
Support Center